Antagonism of Inhibitors of Apoptosis Proteins Reveals a Novel, Immune-Based Therapeutic Approach for T-Cell Lymphoma

Researchers showed that tolinapant acted as an efficacious immunomodulatory molecule capable of inducing complete tumor regression in a syngeneic model of T cell lymphoma exclusively in the presence of an intact immune system.